Scientific publications

• Integrative genomics, personal-genome tests and personalized healthcare: the future is being built today. Brand A. Eur J Hum Genet. 2009 Aug;17(8):977-8

• The integration of genome-based information for common diseases into health policy and healthcare as a major challenge for Public Health Genomics: the example of the methylenetetrahydrofolate reductase gene in non-cancer diseases. Boccia S, Brand A, Brand H, Ricciardi G. Mutat Res. 2009 Jul 10;667(1-2):27-34

• Children and Population biobanks. Gurwitz D, Fortier I, Lunshof JE, Knoppers BM. Science. 2009; 325:818

• Ancestry in translational genomic medicine: handle with care. Gurwitz D, Lunshof JE. Genome Med. 2009; Feb 25;1(2):24

• Sample, data use and protection in biobanking in Europe: legal issues. Zika E, Schulte In den Bäumen T, Kaye J, Brand A, Ibarreta D. Pharmacogenomics. 2008 Jun;9(6):773-81

• Cross-border health activities in the Euregios: good practice for better health. Brand H, Hollederer A, Wolf U, Brand A. Health Policy. 2008 May;86(2-3):245-54

• The impact of genetics and genomics on public health. Brand A, Brand H, Schulte in den Bäumen T. Eur J Hum Genet. 2008 Jan;16(1):5-13

• Misdirected precaution. Prainsack B, Reardon J, Hindmarsh R, Gottweis H, Naue U, Lunshof JE. Nature. 2008; 456:34-35

• From genetic privacy to open consent. Lunshof JE, Chadwick R, Vorhaus DB, Church GM. Nature Reviews Genetics. 2008; 9:406-411

• Hippocrates revisited? Old ideals and new realities. Lunshof JE, Chadwick R, Church GM. Genomic Med. 2008 Jan; 2(1-2):1-3

• Biobanking for epidemiological research and public health. Brand AM, Probst-Hensch NM. Pathobiology. 2007;74(4):227-38

• Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Altman RB, Benowitz N, Gurwitz D, Lunshof JE, Relling M, Lamba J, Wieben E, Mooney S, Giacomini K, Weiss S, Johnson JA, McLeodH, Flockhart D, Weinshilboum R, Shuldiner AR, Roden D, Krauss RM, Ratain M. Pharmacogenomics. 2007; 8 (5) 519

• Getting ready for the future: integration of genomics into public health research, policy and practice in Europe and globally. Brand A, Schroder P, Brand H, Zimmern R. Community Genet. 2006;9(1):67-71

• Public health genetics - experiences and challenges. Brand A, Schroder P. Community Genet. 2006;9(1):5-7

• Personalized medicine: new perspectives - new ethics? Lunshof JE. Personalized Medicine. 2006; 3 (2) 187-1944

• Teaching and practicing pharmacogenomics: a complex matter. Lunshof JE. Pharmacogenomics. 2006; 7 (2) 243-246

• Personalized medicine: decades away? Lunshof JE, Pirmohamed M, Gurwitz D. Pharmacogenomics. 2006; 7 (2) 237-241

• Desperate times call for desperate measures. Lunshof JE. Nature Reviews Genetics. 2006; 7, 162

• A Call for the Creation of Personalized Medicine Databases. Gurwitz D, Lunshof JE, Altman RB. Nature Reviews Drug Discovery. 2006; 5, 23-26

• Public health and genetics - a dangerous combination? Brand A. Eur J Public Health. 2005 Apr;15(2):114-6

• Response to Sykiotis and Papavassiliou: Professional education in molecular medicine - pharmacogenetics first. Gurwitz D, Lunshof JE. Trends in Molecular Medicine. 2005; 11, 485-486

• Consensus Article: Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education. Gurwitz D*, Lunshof J*, Dedoussis G, Flordellis CS, Fuhr U, Kirchheiner J, Licinio J, Llerena A, Manolopoulos VG, Sheffield LJ, Siest G, Torricelli F, Vasiliou V, Wong S. The Pharmacogenomics Journal; 2005. 5, 221-225

• Personalized medicine: how much can we afford? A bioethics perspective. Lunshof JE. Personalized Medicine. 2005; 2(1):43-47

• Pharmacogenomics, Drug Development, and Ethics: Some Points to Consider. Lunshof JE, de Wert G. Drug Development Research. 2004; 62:112-116